✨ Medicine Distribution Consent




NEW ZEALAND GAZETTE, No. 122

26 OCTOBER 2006

3575

Product: Karvezide
Active Ingredients: Hydrochlorothiazide 12.5mg
Irbesartan 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Sanofi Winthrop Industrie, Ambares Et Lagrave, Carbon Blanc Cedex, France

Product: Karvezide
Active Ingredients: Hydrochlorothiazide 12.5mg
Irbesartan 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Sanofi Winthrop Industrie, Ambares Et Lagrave, Carbon Blanc Cedex, France

Product: Neo-B12
Active Ingredient: Hydroxocobalamin chloride 1.027mg equivalent to Hydroxocobalamin 1mg
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma (NZ) Limited
Manufacturer: Hameln Pharmaceuticals GmbH, Hameln, Germany

Product: Stocrin
Active Ingredient: Efavirenz 100mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product: Stocrin
Active Ingredient: Efavirenz 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product: Stocrin
Active Ingredient: Efavirenz 50mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product: Stocrin
Active Ingredient: Efavirenz 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico

Product: Stocrin
Active Ingredient: Efavirenz 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Product: Strepfen Intensive
Active Ingredient: Flurbiprofen 8.75mg
Dosage Form: Lozenge
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, Nottinghamshire, United Kingdom

Product: Sutent
Active Ingredient: Sunitinib malate 16.7mg equivalent to 12.5mg Sunitinib
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Italia Srl, Marino del Tronto, Ascoli Piceno, Italy



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 122


Gazette.govt.nz PDF NZ Gazette 2006, No 122





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
26 October 2006
Medicines Act 1981, Distribution, New Medicines, Arrow Pharmaceuticals, Karvezide, Neo-B12, Stocrin, Strepfen Intensive, Sutent